Company Filing History:
Years Active: 2004-2006
Title: Innovations in GABA-Modifier Screening: The Contributions of Geoffrey White
Introduction
Geoffrey White is an accomplished inventor based in Guilford, CT, known for his significant contributions to the field of pharmaceutical innovation. With a total of three patents to his name, he has focused on developing methods that facilitate the screening of GABA-modulatory compounds, targeting various pharmacological activities that can enhance cognitive and mental health.
Latest Patents
Geoffrey's latest patents revolve around methods for screening GABA-modulatory compounds that are beneficial in identifying compounds with cognitive enhancing properties, anxiolytic properties, hypnotic properties, or antidepressant properties. The patented methods detail how to determine the in vitro efficacy and effective concentration (EC) of these compounds at specific cloned GABA subtype receptors, which are composed of unique variants of α, β, and γ subunits. The innovation also encompasses optional assessments of binding affinities at GABA receptors and suggests that the in vivo effects of the compounds may further be evaluated through animal model testing.
Career Highlights
Geoffrey White currently serves at Neurogen Corporation, where he is actively involved in pioneering research and development aimed at creating therapeutic options for several psychological and neurological conditions. His work is not just limited to his patents; he has also contributed extensively to enhancing the understanding of GABA systems and their implications in pharmacology.
Collaborations
In his journey as an inventor at Neurogen Corporation, Geoffrey collaborates with notable peers such as John Tallman and Dorothy Gallager. Together, they work to leverage their combined expertise, ensuring the successful development of innovative methods that can lead to breakthroughs in mental health therapies.
Conclusion
Geoffrey White continues to play a vital role in the evolution of pharmaceutical science through his innovative patented methods for screening GABA-modulatory compounds. His efforts not only contribute to the advancement of therapeutic options but also exemplify the importance of collaboration in the field of scientific research. With a solid foundation of intellectual properties and promising ongoing projects, Geoffrey's work is crucial in navigating the complex landscape of cognitive enhancement and mental health treatments.